NCT07543419: Italian HS Secukinumab Observational Study
Summary
NIH has registered an observational study (NCT07543419) evaluating treatment patterns with secukinumab in adult patients with moderate to severe hidradenitis suppurativa within the Italian population. The study aims to collect real-world data on treatment response, clinical characteristics, healthcare resource utilization, and economic impact of HS in Italy. No regulatory obligations are imposed by this database entry.
What changed
NIH has registered a new observational study (NCT07543419) titled 'Long Term Observational Study to Collect in a Real-world Population Data on the Treatment Pattern of Secukinumab in Adult Patients With Moderate to Severe HS Within the Italian Population.' The study will evaluate real-world evidence on secukinumab response, treatment patterns, clinical characteristics, healthcare resource utilization, and economic impact in Italian HS patients.
Pharmaceutical companies, clinical investigators, and healthcare providers with an interest in hidradenitis suppurativa research should note this trial registration. No compliance obligations or regulatory deadlines are associated with this database entry.
Archived snapshot
Apr 22, 2026GovPing captured this document from the original source. If the source has since changed or been removed, this is the text as it existed at that time.
Long Term Observational Study to Collect in a Real-world populatIon Data on the Treatment Pattern of Secukinumab in Adult Patients With Moderate to Severe HS Within the Italian Population
Observational NCT07543419 Kind: OBSERVATIONAL Apr 21, 2026
Abstract
The aim of this study is to generate real-world evidence to fill knowledge gaps regarding the response to secukinumab in patients with moderate to severe HS, its treatment patterns, the clinical characteristics of patients on secukinumab, healthcare resource utilization and the economic impact of HS in Italy.
Conditions: Hidradenitis Suppurativa
Related changes
Get daily alerts for ClinicalTrials.gov Studies
Daily digest delivered to your inbox.
Free. Unsubscribe anytime.
Source
About this page
Every important government, regulator, and court update from around the world. One place. Real-time. Free. Our mission
Source document text, dates, docket IDs, and authority are extracted directly from NIH.
The summary, classification, recommended actions, deadlines, and penalty information are AI-generated from the original text and may contain errors. Always verify against the source document.
Classification
Who this affects
Taxonomy
Browse Categories
Get alerts for this source
We'll email you when ClinicalTrials.gov Studies publishes new changes.
Subscribed!
Optional. Filters your digest to exactly the updates that matter to you.